Stay updated with breaking news from Ivir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vir Biotechnology (NASDAQ:VIR – Free Report) had its price target cut by Needham & Company LLC from $32.00 to $22.00 in a research note released on Thursday morning, Benzinga reports. The firm currently has a buy rating on the stock. Several other brokerages have also commented on VIR. SVB Securities dropped their price target on […]
Vir Biotechnology (NASDAQ:VIR – Free Report) had its target price cut by Morgan Stanley from $27.00 to $15.00 in a research report report published on Friday morning, Benzinga reports. They currently have an equal weight rating on the stock. A number of other equities analysts have also issued reports on VIR. TheStreet lowered shares of […]
Vir Biotechnology (NASDAQ:VIR – Free Report) had its price target cut by Needham & Company LLC from $32.00 to $22.00 in a report published on Thursday, Benzinga reports. They currently have a buy rating on the stock. VIR has been the topic of a number of other research reports. SVB Securities reduced their price objective […]
Vir Biotechnology (NASDAQ:VIR – Free Report) had its target price decreased by The Goldman Sachs Group from $51.00 to $28.00 in a research note published on Friday morning, Benzinga reports. The Goldman Sachs Group currently has a buy rating on the stock. Several other equities analysts also recently commented on VIR. Morgan Stanley increased their […]
Viridium Pacific Group Ltd (CVE:VIR – Get Free Report)’s stock price rose 5.6% on Friday . The stock traded as high as C$0.41 and last traded at C$0.38. Approximately 26,500 shares changed hands during mid-day trading, a decline of 71% from the average daily volume of 92,632 shares. The stock had previously closed at C$0.36. […]